Navigation Links
Researchers Identify Lung Failure Therapy Receptor

University of Virginia Health System reserachers have identified a key receptor that could be a potential target for drugs used in the treatment of acute respiratory distress syndrome (ARDS). //The condition is sudden in onset and is a life-threatening condition.

The receptor is similar to what triggers the sense of sight, smell and taste (G-protein coupled receptors) There is no existing treatment for ARDS in which the body's own fluid gets trapped in the lungs and prevents easy breathing. ARDS is caused by pneumonia, septic shock, trauma, or inhaling toxic chemicals. In the current research, it was found that the receptor called CXCR2 attracted neutrophils or the white blood cells, which is the first step in the development of ARDS. “We can’t say yet that if you target this receptor you will stop ARDS,” said Klaus Ley, M.D., Ph.D., director of the cardiovascular research center at UVa. “But it is reasonable to be hopeful and to pursue this type of research that might one day translate into clinical application.” The details of the research appear in the February 16 issue of the “Online First Articles” of The Journal of Clinical Investigation. “Our finding is that expression of this receptor is in the lung itself,” said co-author Dr. J?rg Reutershan, M.D., an anesthesiologist from Germany. “Our hope is that drug companies might be able to target the lung with an aerosol, which would have the advantage of hitting receptor without compromising the entire immune system, which is always a problem. Aerosol treatment would be a great advantage.” Online Article at http://wwwjci.org.
'"/>




Page: 1

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Researchers Identify Lung Failure Therapy Receptor

(Date:9/3/2015)... GA (PRWEB) , ... September 03, 2015 , ... ... cover the cost of graduated compression garments. However, graduated compression garments are an ... Wound care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... ... 03, 2015 , ... RealtyShares , the online marketplace ... investors to real estate investment opportunities nationwide, today announced that it is introducing ... and sponsoring real estate companies. , These products typically involve investors ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... The first ... covering the allegations made by IVC filter lawsuits filed against Bard.** These ... harmed when a Bard IVC filter broke or failed, have recently been consolidated for ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library ... of a comet, the IceCube observatory at the South Pole, and the interior of ... Fall Lecture Series for the world's foremost independently funded research library devoted to science, ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... of comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, ... MD has joined the medical treatment team. As a Staff Psychiatrist, Dr. ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3
... of Vulnerability Management and Operational Whitelisting and Discuss Today,s ... ... Scottsdale, Ariz. (PRWEB) August ... __title__ Vulnerability Management Solutions], a recognized, global leader in ...
... allergies aren,t avoiding the foods they know they shouldn,t eat. ... epinephrine as often as they should be. And instructors, roommates ... if a food-allergic student has a reaction. , These are ... of Michigan Health System. The research suggests that many college ...
... Scott Kornhauser,announced the appointment of Marquita Collins as ... than 20 years of,healthcare industry experience., Her ... of,Aptiv Technology Partners and Regional Operations Director for ... and managing the,entire professional services team and full ...
... NCST ; TSX: NCS), a developer and manufacturer of ... financial results for the second quarter 2008 on Tuesday, August ... 9:00 AM ET on Wednesday,August 13, 2008 to discuss the ... Date: Wednesday, ...
... nevirapine could have downside, study finds , , TUESDAY, Aug. ... used in developing countries to prevent transmission of ... breast milk and blood of mothers, a new Stanford ... the risk that they and their children will develop ...
... emphasize measurement gaps and harmonization, WASHINGTON, ... assessing,clinician performance that can promote higher quality ... endorsed 67 clinician-level consensus,standards relating to cancer ... by thousands of medical professionals who are ...
Cached Medicine News:Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 2Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 3Health News:Students with food allergies often not prepared 2Health News:Students with food allergies often not prepared 3Health News:NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008 2Health News:HIV Drug Might Spur Resistant Strains of Virus 2Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 2Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 3Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 4Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 5Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 6Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 7Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 8Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 9Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 10Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 11
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) ... Devices Packaging Market - By Packaging type, Regions and ... report to their offering. The ... by its end use industry, i.e., Medical devices industry. ... these devices so as to be tamper evident, and ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ... Report on China,s Trastuzumab Market, 2010-2019" report to ... approved by FDA to be used in the clinic ... a major product of Roche. In 2013, the sales ... world. After entering China ...
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2
... - Antigenics Inc.,(NASDAQ: AGEN) today announced additional ... therapeutic cancer vaccine,Oncophage(R) (vitespen). The end-of-study results, ... showed that in a substantial,subset of patients ... disease,recurrence, Oncophage demonstrated a clinically significant,improvement in ...
... product recently approved by FDA for long-term,maintenance ... formoterol fumarate provides improved lung function,comparable to ... and positive safety profile -- , NAPA, ... at the,International Conference of the American Thoracic ...
Cached Medicine Technology:Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
...
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Medicine Products: